Hiroaki Hisakawa

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

Takahiro Ueda, Kohichiro Tsuji, Hiroshi Yoshino et al. · Journal of Clinical Investigation · 2000 · 282 citations · Full text

Life Sciences, Cell Biology, Hematology +16

Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.

Shinsaku Imashuku, Shigeyoshi Hibi, Toshio Ohara et al. · PubMed · 1999 · 195 citations

Medicine, Hematology, Immunology +7

Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region–derived stromal cells

Sahoko Matsuoka, Kohichiro Tsuji, Hiroaki Hisakawa et al. · Blood · 2001 · 178 citations · Full text

Life Sciences, Developmental Biology, Hematology +17

Identification of Severe Combined Immunodeficiency by T-Cell Receptor Excision Circles Quantification Using Neonatal Guthrie Cards

Yoichi Morinishi, Kohsuke Imai, Noriko Nakagawa et al. · The Journal of Pediatrics · 2009 · 120 citations

Life Sciences, Immunology, Pediatrics +12

Persistently High Epstein‐Barr Virus (EBV) Loads in Peripheral Blood Lymphocytes from Patients with Chronic Active EBV Infection

Akihiko Maeda, Hiroshi Wakiguchi, Wakako Yokoyama et al. · The Journal of Infectious Diseases · 1999 · 57 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +15